CARLA ROTH

PARTNER

Carla specialises in molecular biology, biotechnology, biochemistry and pharmaceuticals, with particular expertise in protein therapeutics and second medical uses. Much of her successful practice is dedicated to handling European Patent Office (EPO) opposition proceedings. She has extensive experience in attack and defence both at first instance and appeal and she has been involved in many multiparty disputes. Her experience in antibody-related opposition cases inter alia concerns numerous blockbuster products (such as rituximab, trastuzumab, pertuzumab and adalimumab), epitope related claims, bispecific antibodies, antibody glycosylation as well as recombinant expression technologies and purification methods.